Per M. Almqvist
Corporate Officer/Principal bij Karolinska Institutet
Actieve functies van Per M. Almqvist
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 13-08-2009 | - |
Loopbaan van Per M. Almqvist
Eerdere bekende functies van Per M. Almqvist
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Hoofd Techniek/Wetenschap/O&O | - | - |
Statistieken
Internationaal
| Denemarken | 2 |
| Zweden | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Bok Holding A/S
Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Health Technology |
- Beurs
- Insiders
- Per M. Almqvist
- Ervaring
